ΧΡΗΣΙΜΑ ΑΝΑΓΝΩΣΜΑΤΑ

ΕΜΦΑΝΙΣΗ ΚΑΙ ΕΠΙΠΤΩΣΗ

• Adler CH. Nonmotor complications in Parkinson’s disease. Mov Disord 2005;20(Suppl 11):S23- 29
  
• Barone P, Antonini A, Colosimo C et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 2009;24(11):1641-1649
  
• Carter JH, Stewart BJ, Lyons KS, Archbold PG. Do motor and nonmotor symptoms in PD patients predict caregiver strain and depression? Mov Disord 2008;23(9):1211-1216
  
• Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 2006;5(3):235-245
  
• Chaudhuri KR, Martinez- Martin P, Schapira AH et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 2006;21(7):916-923
  
• Chaudhuri KR, Naidu Y. Early Parkinson’s disease and non-motor issues. J Neurol 2008;255(Suppl 5):33-38
  
• Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson’s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009;8(5):464- 474
  
• Cheon SM, Ha MS, Park MJ, Kim JW. Nonmotor symptoms of Parkinson’s disease: prevalence and awareness of patients and families. Parkinsonism Relat Disord 2008;14(4):286- 290
  
• Cheon SM, Park MJ, Kim WJ, Kim JW. Non-motor off symptoms in Parkinson’s disease. J Korean Med Sci 2009;24(2):311-314
  
• Cubo E, Martin PM, Martin- Gonzalez JA, Rodriguez- Blazquez C, Kulisevsky J. Motor laterality asymmetry and nonmotor symptoms in Parkinson’s disease. Mov Disord 2010;25(1):70-75
  
• Dotchin CL, Jusabani A, Walker RW. Non-motor symptoms in a prevalent population with Parkinson’s disease in Tanzania. Parkinsonism Relat Disord 2009;15(6):457-460
  
• Martinez-Martin P, Schapira AH, Stocchi F et al. Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 2007;22(11):1623-1629
  
• Muzerengi S, Contrafatto D, Chaudhuri KR. Nonmotor symptoms: identification and management. Parkinsonism Relat Disord 2007;13(Suppl 3):S450- 456
  
• O’Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ. Nonmotor symptoms as presenting complaints in Parkinson’s disease: a clinicopathological study. Mov Disord 2008;23(1):101- 106
  
• Pfeiffer RF. Parkinson disease. Nonmotor symptoms in Parkinson disease: the PRIAMO study. Nat Rev Neurol 2009;5(10):531- 532
  
• Poewe W. Non-motor symptoms in Parkinson’s disease. Eur J Neurol 2008;15 Suppl 1:14-20
  
• Rodriguez-Oroz MC, Jahanshahi M, Krack P et al. Initial clinical manifestations of Parkinson’s disease: features and pathophysiological mechanisms. Lancet Neurol 2009;8(12):1128- 1139
  
• Simuni T, Sethi K. Nonmotor manifestations of Parkinson’s disease. Ann Neurol 2008;64(Suppl 2):S65-80
  
• Stacy M, Hauser R. Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson’s disease. J Neural Transm 2007;114(2):211-217
  
• Zesiewicz TA, Sullivan KL, Hauser RA. Nonmotor symptoms of Parkinson’s disease. Expert Rev Neurother 2006;6(12):1811-1822

ΣΥΜΠΤΩΜΑΤΑ ΣΤΗ ΓΝΩΣΤΙΚΗ ΛΕΙΤΟΥΡΓΙΑ ΚΑΙ ΨΥΧΙΑΤΡΙΚΑ ΣΥΜΠΤΩΜΑΤΑ

• Aarsland D, Beyer MK, Kurz MW. Dementia in Parkinson’s disease. Curr Opin Neurol 2008;21(6):676- 682
• Barbas NR. Cognitive, affective, and psychiatric features of Parkinson’s disease. Clin Geriatr Med 2006;22(4):773-796, v-vi 
• Galvin JE. Cognitive change in Parkinson disease. Alzheimer Dis Assoc Disord 2006;20(4):302- 310
  
• Goetz CG, Emre M, Dubois B. Parkinson’s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 2008;64(Suppl 2):S81-92
• Jones CA, Pohar SL, Patten SB. Major depression and health-related quality of life in Parkinson’s disease. Gen Hosp Psychiatry 2009;31(4):334-340
  
• Martinez-Martin P, Rodriguez-Blazquez C, Abe K et al. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 2009;73(19):1584-1591
  
• Montel S, Bonnet AM, Bungener C. Quality of life in relation to mood, coping strategies, and dyskinesia in Parkinson’s disease. J Geriatr Psychiatry Neurol 2009;22(2):95-102
  
• Pacchetti C, Manni R, Zangaglia R et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson’s disease. Mov Disord 2005;20(11):1439-1448
  
• Reijnders JS, Ehrt U, Lousberg R, Aarsland D, Leentjens AF. The association between motor subtypes and psychopathology in Parkinson’s disease. Parkinsonism Relat Disord 2009;15(5):379-382
  
• Richard IH. Depression and apathy in Parkinson’s disease. Curr Neurol Neurosci Rep 2007;7(4):295-301
  
• Stamey W, Jankovic J. Impulse control disorders and pathological gambling in patients with Parkinson disease. Neurologist 2008;14(2):89-99
  
• Verbaan D, Marinus J, Visser M et al. Cognitive impairment in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2007;78(11):1182-1187
  
• Verbaan D, van Rooden SM, Visser M, Marinus J, Emre M, van Hilten JJ. Psychotic and compulsive symptoms in Parkinson’s disease. Mov Disord 2009;24(5):738-744
• Weintraub D, Comella CL, Horn S. Parkinson’s disease--Part 3: Neuropsychiatric symptoms. Am J Manag Care 2008;14(2 Suppl):S59-69
  
• Wolters E. PD-related psychosis: pathophysiology with therapeutical strategies. J Neural Transm Suppl 2006(71):31-37

ΔΙΑΤΑΡΑΧΕΣ ΥΠΝΟΥ, ΚΟΠΩΣΗ

• Comella CL. Sleep disorders in Parkinson’s disease: an overview. Mov Disord 2007;22 Suppl 17:S367- 373
  
• Gunn DG, Naismith SL, Lewis SJ. Sleep disturbances in Parkinson disease and their potential role in heterogeneity. J Geriatr Psychiatry Neurol 2010;23(2):131-7
• Hagell P, Brundin L. Towards an understanding of fatigue in Parkinson disease. J Neurol Neurosurg Psychiatry 2009;80(5):489-492

ΣΥΜΠΤΩΜΑΤΑ ΤΟΥ ΑΥΤΟΝΟΜΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ, ΠΟΝΟΣ

• Beiske AG, Loge JH, Ronningen A, Svensson E. Pain in Parkinson’s disease: prevalence and characteristics. Pain 2009;141(1-2- ):173-177
  
• Defazio G, Berardelli A, Fabbrini G et al. Pain as a nonmotor symptom of Parkinson disease: evidence from a casecontrol study. Arch Neurol 2008;65(9):1191-1194
• Evatt ML, Chaudhuri KR, Chou KL et al. Dysautonomia rating scales in Parkinson’s disease: sialorrhea, dysphagia, and constipation – critique and recommendations by movement disorders task force on rating scales for Parkinson’s disease. Mov Disord 2009;24(5):635-646
  
• Merello M. Sialorrhoea and drooling in patients with Parkinson’s disease: epidemiology and management. Drugs Aging 2008;25(12):1007-1019
• Nebe A, Ebersbach G. Pain intensity on and off levodopa in patients with Parkinson’s disease. Mov Disord 2009;24(8):1233- 1237
  
• Poewe W. Dysautonomia and cognitive dysfunction in Parkinson’s disease. Mov Disord 2007;22(Suppl 17):S374-378
  
• Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, van Hilten JJ. Patient-reported autonomic symptoms in Parkinson disease. Neurology 2007;69(4):333-341
• Winge K, Fowler CJ. Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management. Mov Disord 2006;21(6):737-745

ΘΕΡΑΠΕΙΕΣ

• Chan DK, Cordato DJ, O’Rourke F. Management for motor and non-motor complications in late Parkinson’s disease. Geriatrics 2008;63(5):22-27
  
• Coelho M, Ferreira J, Rosa M, Sampaio C. Treatment options for non-motor symptoms in late-stage Parkinson’s disease. Expert Opin Pharmacother 2008;9(4):523-535
• Fujimoto K. Management of non-motor complications in Parkinson’s disease. J Neurol 2009;256(Suppl 3):299-305
  
• Honig H, Antonini A, Martinez- Martin P et al. Intrajejunal levodopa infusion in Parkinson’s disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Mov Disord 2009;24(10):1468-1474
• Horstink M, Tolosa E, Bonuccelli U, Deuschl G, Friedman A, Kanovsky P, Larsen JP, Lees A, Oertel W, Poewe W, Rascol O, Sampaio C; European Federation of Neurological Societies; Movement Disorder Society-European Section. Review of the therapeutic management of Parkinson’s disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson’s disease. Eur J Neurol. 2006;13(11):1186-1202
  
• Kim HJ, Park SY, Cho YJ et al. Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment. J Neurol Sci 2009;287(1-2):200- 204
• Lemke MR. Dopamine agonists in the treatment of non-motor symptoms of Parkinson’s disease: depression. Eur J Neurol 2008;15(Suppl 2):9-14
  
• Lou JS, Dimitrova DM, Park BS et al. Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study. Clin Neuropharmacol 2009;32(6):305-310
  
• Nyholm D, Scott B. Patientperceived outcome of duodenal levodopa infusion in advanced Parkinson’s disease. European Neurological Journal 2010; 2(1):1-8
• Reichmann H, Ziemssen T. Treatment strategies for nonmotor manifestations of Parkinson’s disease. Expert Opin Pharmacother 2009;10(5):773-784
• Rektorova I, Balaz M, Svatova J et al. Effects of ropinirole on nonmotor symptoms of Parkinson disease: a prospective multicenter study. Clin Neuropharmacol 2008;31(5):261-266
  
• Stacy MA, Murck H, Kroenke K. Responsiveness of motor and nonmotor symptoms of Parkinson disease to dopaminergic therapy. Prog Neuropsychopharmacol Biol Psychiatry 2010;34(1):57- 61
  
• Witjas T, Kaphan E, Regis J et al. Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson’s disease. Mov Disord 2007;22(12):1729- 1734
• Zibetti M, Torre E, Cinquepalmi A et al. Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the subthalamic nucleus. Eur Neurol 2007;58(4):218-223